Laurent Pharmaceuticals is a biopharmaceutical company developing a new treatment paradigm in addressing chronic inflammatory diseases, by using body’s own ability to resolve the inflammation process. Laurent’s lead program (LAU-7b) is a first-in-class oral endogenous modulator of DHA (docosahexaenoic acid), the pathway that triggers the resolution phase of inflammation.
Laurent Pharmaceuticals is a biopharmaceutical company developing a new treatment paradigm in addressing chronic inflammatory diseases, by using body’s own ability to resolve the inflammation process. Laurent’s lead program (LAU-7b) is a first-in-class oral endogenous modulator of DHA (docosahexaenoic acid), the pathway that triggers the resolution phase of inflammation.
- Sector
- Life Sciences
- Stage
- Seed
- Status
- Active